Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine

Document first published:
Page updated:
Topic:
,
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine to individuals from 12 years of age in accordance with the national COVID-19 vaccination programme. Current versions of PHE/UKHSA developed COVID-19 vaccine PGDs can be found via: GOV.UK: COVID-19 vaccination programme

Document

Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine (PDF version) - From 31 March

Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine (PDF version) - From 31 March

  • PDF
  • 507 KB
  • 27 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Updated 31 March 2022.

Document

Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine (Word version)

Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine (Word version)

  • Microsoft Word
  • 261 KB
  • 27 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Updated 31 March 2022.